Cita APA (7a ed.)
Mikus, G., Foerster, K. I., Terstegen, T., Vogt, C., Said, A., Schulz, M., & Haefeli, W. E. (2022). Oral Drugs Against COVID-19: Management of Drug Interactions With the Use of Nirmatrelvir/Ritonavir. Deutsches Ärzteblatt International, 119(15), 263-273.
Cita Chicago Style (17a ed.)
Mikus, Gerd, Kathrin I. Foerster, Theresa Terstegen, Cathrin Vogt, André Said, Martin Schulz, y Walter E. Haefeli. "Oral Drugs Against COVID-19: Management of Drug Interactions With the Use of Nirmatrelvir/Ritonavir." Deutsches Ärzteblatt International 119, no. 15 (2022): 263-273.
Cita MLA (9a ed.)
Mikus, Gerd, et al. "Oral Drugs Against COVID-19: Management of Drug Interactions With the Use of Nirmatrelvir/Ritonavir." Deutsches Ärzteblatt International, vol. 119, no. 15, 2022, pp. 263-273.
Precaución: Estas citas no son 100% exactas.